We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Tailored synthesis of pH-responsive biodegradable microcapsules incorporating gelatin, alginate, and hyaluronic acid for effective-controlled release
Summary
Researchers synthesized biodegradable pH-responsive microcapsules from gelatin, alginate, and hyaluronic acid as an alternative to conventional plastic-based drug delivery systems. The capsules demonstrated effective controlled release of vitamin E with high encapsulation efficiency and responded to different pH conditions. The study presents a sustainable approach to microencapsulation that avoids generating microplastic pollution from synthetic polymer capsules.
In response to escalating environmental concerns and the urgent need for sustainable drug delivery systems, this study introduces biodegradable pH-responsive microcapsules synthesized from a blend of gelatin, alginate, and hyaluronic acid. Employing the coacervation process, capsules were created with a spherical shape, multicore structure, and small sizes ranging from 10 to 20 μm, which exhibit outstanding vitamin E encapsulation efficiency. With substantial incorporation of hyaluronic acid, a pH-responsive component, the resulting microcapsules displayed noteworthy swelling behavior, facilitating proficient core ingredient release at pH 5.5 and 7.4. Notably, these capsules can effectively deliver active substances to the dermal layer under specific skin conditions, revealing promising applications in topical medications and cosmetics. Furthermore, the readily biodegradable nature of the designed capsules was demonstrated through Biochemical Oxygen Demand (BOD) testing, with over 80 % of microcapsules being degraded by microorganisms after one week of incubation. This research contributes to the development of responsive microcapsules and aligns with broader environmental initiatives, offering a promising pathway to mitigate the impact of microplastics while advancing various applications.
Sign in to start a discussion.